PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

about

Recent advances of bispecific antibodies in solid tumors.PSMA redirects MAPK to PI3K-AKT signaling to promote prostate cancer progression.Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.

P2860

Q41696278-30C55D41-ECAC-4DA2-B855-95CE3E433457 Q47861575-AAC7577C-3FA7-462F-AB03-4CB162E23DFA Q49567029-DBBB5CCC-9C49-41CB-B992-3F43509C8091

P2860

PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

Item

http://www.wikidata.org/entity/Q41273648

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

PSMA redirects cell survival s ...... rogression of prostate cancer.

@en

type

Item

label

PSMA redirects cell survival s ...... rogression of prostate cancer.

@en

prefLabel

PSMA redirects cell survival s ...... rogression of prostate cancer.

@en

P1476

PSMA redirects cell survival s ...... rogression of prostate cancer.

@en

P2093

Christina L Grant

http://www.w3.org/2001/XMLSchema#string

Fernando A Ferrer

http://www.w3.org/2001/XMLSchema#string

Kristina Dortche

http://www.w3.org/2001/XMLSchema#string

M Mamunur Rahman

http://www.w3.org/2001/XMLSchema#string

P2860

Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth

Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death

Cancer treatment and survivorship statistics, 2012

Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen

Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay

Activation of Integrin-RACK1/PKCalpha signalling in human articular chondrocyte mechanotransduction

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease

Survivin mediates resistance to antiandrogen therapy in prostate cancer

The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy

Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit

P31

scholarly article

P356

10.1126/SCISIGNAL.AAG3326

http://www.w3.org/2001/XMLSchema#string

P433

470

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Linda H Shapiro

Leslie A Caromile

Christopher Stoddard

P577

2017-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28292957

http://www.w3.org/2001/XMLSchema#string

P932

5545931

http://www.w3.org/2001/XMLSchema#string

PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

about

P2860

P2860

PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932